The emerging class of GLP-1 agonist medication and GIP combined medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, provide significant progress in metabolic management . https://peptide-science098235.bloggingplay.com/64064/semaglutide-a-detailed-review